Delivery Order SPE2DB20D3103-SPE2DB24FM8H7
Award Date
2/27/24
Potential Completion Date
2/28/24
Potential Value
$17K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Cencora, Inc.
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of Stelara 45 mg/0.5 ml syringes. The contract has a ceiling value of $5,563.16 and an ultimate completion date of September 11, 2024. The contract is a firm fixed price type and does not have a set-aside designation. Amerisourcebergen is a significant supplier of pharmaceutical products and medical supplies to various government agencies,...
This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,343.24, is for the delivery of Stelara 45 mg/0.5 ml syringe 0.5 ml, a specialty medication, to support the DLA's medical supply requirements. The contract is a Firm Fixed Price Delivery Order with a completion date of December 27, 2023. Amerisourcebergen Drug Corp is a subsidiary of the parent...
This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of Stelara 45 mg/0.5 ml syringes, with a ceiling value of $18,305.11 and a completion date of September 28, 2023. The contract is a Firm Fixed Price Delivery Order, without any set-aside designation, indicating open competition. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which...
This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $17,987.20, is a delivery order for the pharmaceutical product STELARA 45 MG/0.5 ML SYRINGE 0.5ML. The contract has an ultimate completion date of January 15, 2025 and is a firm fixed-price contract. There is no set-aside designation for this award. Amerisourcebergen holds a significant...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of Stelara 45 mg/0.5 ml syringes. The contract, valued at $3,281.21, is a firm fixed-price delivery order with a completion date of March 22, 2022. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which holds a significant Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 with the DLA...
This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has an award value of $5,735.60 and covers the delivery of Stelara 45 mg/0.5 ml syringes. The contract type is a Delivery Order under a Firm Fixed Price arrangement, with a period of performance through January 2, 2025. This award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999...
This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distribution company, for the delivery of Stelara 90 mg/ml syringes. The contract has a ceiling value of $6,715.70 and a completion date of May 16, 2024. It is a firm fixed price delivery order contract, without any set-aside designation. Amerisourcebergen Drug Corp holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of Stelara 90 mg/ml syringes. The contract, valued at $11,975.26, was awarded by the Defense Logistics Agency (DLA) and has an ultimate completion date of April 16, 2024. The contract is a delivery order and is priced as a firm fixed price. This contract is not associated with a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp is a subsidiary of the...
This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distribution company, for the supply of Stelara 45 mg/0.5 ml syringes. The contract has a ceiling value of $3,678.95 and a period of performance through February 6, 2024. The contract is a delivery order with a firm fixed-price pricing type, and it does not have any set-aside designations. AmerisourceBergen Drug Corp is a subsidiary of the parent company Cencora,...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of Stelara 45 mg/0.5 ml syringes. The ceiling value of the Delivery Order is $13,124.84, with a completion date of September 19, 2022. Amerisourcebergen Drug Corp is a subsidiary of Cencora, Inc., which is the parent company. This contract award is not designated as a set-aside and was awarded under full and open competition....